Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ERAS |
---|---|---|
09:32 ET | 45676 | 2.13 |
09:34 ET | 4100 | 2.15 |
09:36 ET | 794 | 2.14 |
09:38 ET | 600 | 2.115 |
09:39 ET | 550 | 2.115 |
09:41 ET | 2200 | 2.12 |
09:43 ET | 1700 | 2.125 |
09:45 ET | 800 | 2.125 |
09:48 ET | 3700 | 2.12 |
09:50 ET | 100 | 2.12 |
09:52 ET | 800 | 2.11 |
09:54 ET | 8005 | 2.12 |
09:56 ET | 4410 | 2.11 |
09:57 ET | 800 | 2.12 |
09:59 ET | 200 | 2.11 |
10:01 ET | 3241 | 2.13 |
10:03 ET | 30572 | 2.145 |
10:06 ET | 9071 | 2.155 |
10:08 ET | 3000 | 2.15 |
10:10 ET | 59715 | 2.175 |
10:12 ET | 2000 | 2.175 |
10:14 ET | 13844 | 2.19 |
10:15 ET | 475 | 2.195 |
10:17 ET | 600 | 2.195 |
10:21 ET | 6033 | 2.205 |
10:24 ET | 6514 | 2.195 |
10:26 ET | 2994 | 2.185 |
10:28 ET | 100 | 2.19 |
10:30 ET | 700 | 2.185 |
10:32 ET | 1083 | 2.184 |
10:35 ET | 200 | 2.185 |
10:37 ET | 500 | 2.185 |
10:39 ET | 4351 | 2.185 |
10:44 ET | 5361 | 2.2 |
10:46 ET | 200 | 2.2 |
10:48 ET | 6215 | 2.175 |
10:51 ET | 4029 | 2.175 |
10:53 ET | 100 | 2.175 |
10:55 ET | 2807 | 2.17 |
10:57 ET | 4500 | 2.17 |
11:00 ET | 100 | 2.165 |
11:02 ET | 1000 | 2.17 |
11:08 ET | 1895 | 2.17 |
11:09 ET | 2600 | 2.17 |
11:15 ET | 100 | 2.17 |
11:18 ET | 200 | 2.165 |
11:22 ET | 369 | 2.16 |
11:24 ET | 300 | 2.165 |
11:33 ET | 738 | 2.162 |
11:40 ET | 100 | 2.165 |
11:45 ET | 5194 | 2.174 |
11:47 ET | 400 | 2.18 |
11:49 ET | 361 | 2.18 |
11:51 ET | 800 | 2.175 |
11:54 ET | 200 | 2.17 |
11:56 ET | 1048 | 2.17 |
11:58 ET | 4888 | 2.165 |
12:00 ET | 300 | 2.16 |
12:02 ET | 200 | 2.16 |
12:03 ET | 100 | 2.16 |
12:05 ET | 288 | 2.16 |
12:07 ET | 886 | 2.165 |
12:09 ET | 200 | 2.16 |
12:12 ET | 12285 | 2.165 |
12:14 ET | 200 | 2.165 |
12:16 ET | 200 | 2.165 |
12:18 ET | 300 | 2.17 |
12:20 ET | 300 | 2.165 |
12:21 ET | 1000 | 2.165 |
12:23 ET | 400 | 2.165 |
12:25 ET | 400 | 2.165 |
12:27 ET | 500 | 2.16 |
12:30 ET | 2034 | 2.165 |
12:32 ET | 3712 | 2.165 |
12:34 ET | 1000 | 2.165 |
12:36 ET | 3433 | 2.165 |
12:38 ET | 1208 | 2.165 |
12:39 ET | 18741 | 2.164 |
12:41 ET | 1381 | 2.165 |
12:43 ET | 1615 | 2.16 |
12:45 ET | 1300 | 2.16 |
12:48 ET | 2759 | 2.17 |
12:50 ET | 1400 | 2.16 |
12:52 ET | 1989 | 2.165 |
12:54 ET | 1300 | 2.16 |
12:56 ET | 1000 | 2.165 |
12:57 ET | 2722 | 2.16 |
12:59 ET | 500 | 2.165 |
01:01 ET | 300 | 2.165 |
01:03 ET | 200 | 2.165 |
01:06 ET | 800 | 2.165 |
01:08 ET | 400 | 2.165 |
01:10 ET | 958 | 2.16 |
01:12 ET | 500 | 2.16 |
01:14 ET | 804 | 2.16 |
01:15 ET | 300 | 2.16 |
01:17 ET | 200 | 2.16 |
01:19 ET | 597 | 2.16 |
01:21 ET | 809 | 2.17 |
01:24 ET | 700 | 2.165 |
01:26 ET | 800 | 2.17 |
01:28 ET | 1000 | 2.165 |
01:30 ET | 300 | 2.16 |
01:32 ET | 200 | 2.165 |
01:33 ET | 100 | 2.16 |
01:35 ET | 1615 | 2.16 |
01:37 ET | 941 | 2.17 |
01:39 ET | 300 | 2.16 |
01:42 ET | 600 | 2.17 |
01:44 ET | 5621 | 2.18 |
01:46 ET | 1000 | 2.18 |
01:48 ET | 6000 | 2.18 |
01:50 ET | 1050 | 2.18 |
01:51 ET | 2034 | 2.18 |
01:53 ET | 900 | 2.175 |
01:55 ET | 500 | 2.17 |
01:57 ET | 200 | 2.17 |
02:00 ET | 1700 | 2.175 |
02:02 ET | 800 | 2.18 |
02:04 ET | 300 | 2.17 |
02:06 ET | 1632 | 2.175 |
02:08 ET | 1400 | 2.18 |
02:09 ET | 600 | 2.175 |
02:11 ET | 500 | 2.18 |
02:13 ET | 1429 | 2.18 |
02:15 ET | 900 | 2.18 |
02:18 ET | 1000 | 2.17 |
02:20 ET | 2578 | 2.18 |
02:22 ET | 500 | 2.18 |
02:24 ET | 700 | 2.175 |
02:26 ET | 400 | 2.175 |
02:27 ET | 700 | 2.18 |
02:29 ET | 300 | 2.175 |
02:31 ET | 918 | 2.175 |
02:33 ET | 1763 | 2.17 |
02:36 ET | 2936 | 2.17 |
02:38 ET | 500 | 2.18 |
02:40 ET | 400 | 2.17 |
02:42 ET | 5900 | 2.18 |
02:44 ET | 1100 | 2.175 |
02:45 ET | 932 | 2.175 |
02:47 ET | 5300 | 2.18 |
02:49 ET | 1300 | 2.175 |
02:51 ET | 1320 | 2.17 |
02:54 ET | 14397 | 2.16 |
02:56 ET | 500 | 2.165 |
02:58 ET | 1400 | 2.165 |
03:00 ET | 931 | 2.165 |
03:02 ET | 700 | 2.16 |
03:03 ET | 400 | 2.165 |
03:05 ET | 300 | 2.16 |
03:07 ET | 300 | 2.16 |
03:09 ET | 2890 | 2.165 |
03:12 ET | 500 | 2.165 |
03:14 ET | 700 | 2.16 |
03:16 ET | 597 | 2.165 |
03:18 ET | 300 | 2.16 |
03:20 ET | 392 | 2.165 |
03:21 ET | 4456 | 2.165 |
03:23 ET | 400 | 2.165 |
03:25 ET | 800 | 2.17 |
03:27 ET | 1309 | 2.165 |
03:30 ET | 400 | 2.16 |
03:32 ET | 200 | 2.165 |
03:34 ET | 400 | 2.165 |
03:36 ET | 5942 | 2.165 |
03:38 ET | 835 | 2.165 |
03:39 ET | 700 | 2.165 |
03:41 ET | 1100 | 2.165 |
03:43 ET | 2300 | 2.165 |
03:45 ET | 1500 | 2.165 |
03:48 ET | 6021 | 2.165 |
03:50 ET | 2800 | 2.165 |
03:52 ET | 2851 | 2.165 |
03:54 ET | 2100 | 2.165 |
03:56 ET | 3433 | 2.165 |
03:57 ET | 14960 | 2.16 |
03:59 ET | 61844 | 2.17 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Erasca Inc | 516.4M | -2.6x | --- |
Cassava Sciences Inc | 490.1M | -8.7x | --- |
Mind Medicine (MindMed) Inc | 508.9M | -2.4x | --- |
Oric Pharmaceuticals Inc | 518.5M | -4.2x | --- |
Corbus Pharmaceuticals Holdings Inc | 537.6M | -7.2x | --- |
PepGen Inc | 545.9M | -5.2x | --- |
Erasca, Inc. is a clinical-stage precision oncology company. The Company is focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The Company has assembled a wholly owned or controlled RAS/MAPK pathway-focused pipeline in the industry, which is focused on modality-agnostic programs aligned with its three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes three clinical-stage programs, such as a pan-RAF inhibitor, an ERK inhibitor, and a central nervous system (CNS)-penetrant EGFR inhibitor, and additional discovery-stage programs targeting other key oncogenic drivers. Its lead product candidate is naporafenib, a pan-RAF inhibitor with the potential for patients with NRAS-mutated (NRASm) melanoma, RAS Q61X solid tumors, and other RAS/MAPK pathway-driven tumors.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $516.4M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 238.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.84 |
Book Value | $2.10 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.